- Home
- ORKA vs MERC Comparison
ORKA vs MERC Comparison
Compare ORKA & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- MERC
- Stock Information
- Founded
- ORKA 2004
- MERC 1968
- Country
- ORKA United States
- MERC Canada
- Employees
- ORKA N/A
- MERC N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MERC Paper
- Sector
- ORKA Health Care
- MERC Basic Materials
- Exchange
- ORKA Nasdaq
- MERC Nasdaq
- Market Cap
- ORKA 429.4M
- MERC 468.8M
- IPO Year
- ORKA N/A
- MERC 1987
- Fundamental
- Price
- ORKA $8.92
- MERC $5.27
- Analyst Decision
- ORKA Strong Buy
- MERC Hold
- Analyst Count
- ORKA 7
- MERC 2
- Target Price
- ORKA $39.67
- MERC $7.75
- AVG Volume (30 Days)
- ORKA 272.6K
- MERC 337.4K
- Earning Date
- ORKA 03-06-2025
- MERC 05-08-2025
- Dividend Yield
- ORKA N/A
- MERC 5.64%
- EPS Growth
- ORKA N/A
- MERC N/A
- EPS
- ORKA N/A
- MERC N/A
- Revenue
- ORKA N/A
- MERC $2,043,360,000.00
- Revenue This Year
- ORKA N/A
- MERC $3.26
- Revenue Next Year
- ORKA N/A
- MERC $5.78
- P/E Ratio
- ORKA N/A
- MERC N/A
- Revenue Growth
- ORKA N/A
- MERC 2.48
- 52 Week Low
- ORKA $8.66
- MERC $5.21
- 52 Week High
- ORKA $53.88
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- MERC 28.52
- Support Level
- ORKA N/A
- MERC $6.45
- Resistance Level
- ORKA N/A
- MERC $6.78
- Average True Range (ATR)
- ORKA 0.00
- MERC 0.27
- MACD
- ORKA 0.00
- MERC -0.10
- Stochastic Oscillator
- ORKA 0.00
- MERC 3.82
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.